CompletedNCT00946348
Cannabis use and dronabinol in people with schizophrenia
About this title
Read the official source — NCT00946348Medication studyAges 18–50United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 50 years.
- Listed locations
- LebanonSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateDecember 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 12
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT00946348
- Official title
Show the full official title
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Lebanon
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Dartmouth-Hitchcock Medical Center, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Dronabinol and Cannabis.
Who was this study for?
Listed age limits: 18 years to 50 years.
